AppMed
Developer and operator of a cloud-hosted regulated clinical decision-support platform (SaMD Class II in Canada) that unifies patient-reported outcomes, medication telemetry and at‑home volumetric microsampling into a single clinician dashboard. The platform supports model-informed precision dosing (PK/PD), remote therapeutic drug monitoring, objective adherence telemetry, configurable clinical alerts, exportable longitudinal datasets for research, and institutional governance controls. Services include rapid institutional deployment, multisite research enablement, distribution and logistics for microsampling kits, and structured data licensing. Hosting and data governance are designed for Canadian data residency and regulatory compliance.
Industries
Nr. of Employees
small (1-50)
Patents
System and method for monitoring and identifying posology efficacy for an an individual
US-11185282-B2
View Details
System and method for monitoring and identifying posology efficacy for an an individual
US-11185282-B2
View DetailsProducts
Regulated clinical decision-support platform (SaMD Class II)
Cloud-hosted clinical platform that unifies validated patient-reported outcomes, medication adherence telemetry and biomarker results from at-home volumetric microsampling into a single, role-based dashboard to support continuous clinical decision-making and research data generation.
Regulated clinical decision-support platform (SaMD Class II)
Cloud-hosted clinical platform that unifies validated patient-reported outcomes, medication adherence telemetry and biomarker results from at-home volumetric microsampling into a single, role-based dashboard to support continuous clinical decision-making and research data generation.
Services
Institutional onboarding, governance and technical configuration, clinical workflow setup, training and dedicated account management; typical deployment under four weeks.
Support for multisite and federated research protocols, standardized data capture, de-identified dataset licensing and exportable datasets for biostatistics and regulatory submissions.
Provisioning, customization and distribution of volumetric microsampling devices and at-home collection kits with prepaid shipping options and chain-of-custody tracking into accredited laboratories; supports kit quantity pricing and study-specific kit configuration.
Standards-based API integration (HL7 FHIR, REST) and technical integration support for EHRs, REDCap and institutional data warehouses.
Condition-specific pilot programs, clinical demonstrations and tailored proof-of-concept engagements leveraging existing clinical network and consent frameworks.
Institutional onboarding, governance and technical configuration, clinical workflow setup, training and dedicated account management; typical deployment under four weeks.
Support for multisite and federated research protocols, standardized data capture, de-identified dataset licensing and exportable datasets for biostatistics and regulatory submissions.
Provisioning, customization and distribution of volumetric microsampling devices and at-home collection kits with prepaid shipping options and chain-of-custody tracking into accredited laboratories; supports kit quantity pricing and study-specific kit configuration.
Standards-based API integration (HL7 FHIR, REST) and technical integration support for EHRs, REDCap and institutional data warehouses.
Condition-specific pilot programs, clinical demonstrations and tailored proof-of-concept engagements leveraging existing clinical network and consent frameworks.
Expertise Areas
- Deployment of regulated clinical decision-support software (SaMD)
- Remote patient monitoring with continuous PRO collection
- Model-informed precision dosing and PK/PD simulation
- Remote therapeutic drug monitoring using volumetric microsampling
Key Technologies
- Bayesian population PK/PD modelling
- Volumetric absorptive microsampling (VAMS) and dried-microsample formats
- Minimally invasive skin microbiopsy devices
- RNA stabilization reagents for microsamples
News & Updates
Platform is authorized in Canada as a Software as a Medical Device (SaMD) Class II.
Company reports granted patents covering core methodologies in individualized posology and related provisional filings in major jurisdictions.
Mutual intent to integrate end-to-end microsampling and biomarker analysis workflows with accredited laboratories and to distribute validated microsampling devices within Canada.
Platform is authorized in Canada as a Software as a Medical Device (SaMD) Class II.
Company reports granted patents covering core methodologies in individualized posology and related provisional filings in major jurisdictions.
Mutual intent to integrate end-to-end microsampling and biomarker analysis workflows with accredited laboratories and to distribute validated microsampling devices within Canada.